Global Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Market Definition:

Thyroid cancer is a type of cancer that begins in the par follicular and follicular thyroid cells of the thyroid gland. Thyroid cancer treatment options include surgical removal of the thyroid gland, radioactive ablation, and TSH suppression therapy. Iodine is absorbed by thyroid cells and converted into triiodothyronine (T3) and thyroxine. These hormones are released into the bloodstream and play an important role in the regulation of metabolism. A healthy thyroid gland produces approximately 80% T4 and 20% T3.

Market Segmentation:

The global thyroid cancer diagnostics market is categorized into seven notable segments based on product type, test type, cancer type, stages, age group, end user and distribution channel.
• On the basis of product type, the global thyroid cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the global thyroid cancer diagnostics market is segmented into imaging test, blood test, biopsy, others
• On the basis of Cancer type, the global thyroid cancer diagnostics market is segmented into papillary carcinoma, follicular carcinoma, others
• On the basis of Stage, the global thyroid cancer diagnostics market is segmented into Stage I, Stage II, Stage III, Stage IV)
• On the basis of Age group, the global thyroid cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, Below 21
• On the basis of end user, the global thyroid cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, others
• On the basis of distribution channel, the global thyroid cancer diagnostics market is segmented into direct tender and retail sales

Market Players

Some of the major players operating in the global thyroid cancer diagnostics market are:
• Canon Inc.
• FUJIFILM Holdings Corporation
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Illumina
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Abbott
• General Electric Company
• BD
• QIAGEN
• DIASORIN S.P.A.
• Merck KGaA
• Hologic
• Myriad Genetics Inc.
• BIOMERIEUX
• FONAR Corp.
• Time Medical Holding.
• PlexBio.
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• Beijing O&D Biotech Co., Ltd.
• SternMed GmbH